维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="Feferman"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Breakage of tolerance to hidden cyto plasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis显示文摘	Feferman T Im SH Fuchs S	2003	Neuroimmunol2003，140，12：	1
2	Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis 显示文摘	Aricha R Feferman T Fuchs S	2008	J Immunol2008，180，4：	1
3	rotective molecular mimicry in experimental myasthenia gravis显示文摘	Im SH Barchan D Feferman T	2002	J Neuroimmunol2002，126，：	1
4	Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis显示文摘	Feferman T Maiti PK Berrih-Aknin S	2005	J Immunol2005，174，9：	1
5	Thalidomide reduces vascular density in granulation tissue of subcutaneously implangted polyvinyl alcohol sponges in guinea pigs 显示文摘	Or R Feferman R Shoshan S	1998	Exp Hematol1998，26，3：	1
6	Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis 显示文摘	Feferman T Im SH Fuchs S	2003	J Neuroimmunol2003，140，12：	1
7	Ex vivo generated regula- tory T cells modulate experimental autoimmune myasthenia gravis 显示文摘	Aricha R Feferman T Fuchs S	2008	J Immunol2008，180，4：	1
8	Suppression of experimental autoimmune myasthenia gravis by intravenous immtmoglobulin and isolation of a disease- specific IgG fraction显示文摘	Fuchs S Feferman T Zhu K Y	2007	Ann N Y Acad Sci2007，1110，：	1
9	Involvement of phosphodiesterase in autoimmune diseases显示文摘	Mizrachi K Arieha R Feferman T	2010	J Neuroimmunol2010，220，13：	1
10	Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors显示文摘	Souroujon MC Maiti PK Feferman T	2003	Ann NY Acad Sci2003，998，1：	1
11	Reduction in puhnonary fibrosis in vivo by halofuginone 显示文摘	Nagler A Firman N Feferman R	1996	Am J Respir Crit Care Med1996，154，4：	1
12	The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation显示文摘	Monsonego-Organ E Adar R Feferman T	2007	Mol Cell Biol2007，20，2：	1
13	-Overexp^ession ofIFN-induced protein 10 and its receptOT CXCR3 in myastheniagravis显示文摘	Feferman T Maiti PK Berrih-Aknin S	2005	J Immunol2005，174，9：	1
14	The transmembrane mutation G380R in fibroblast growth fac- tor receptor 3 uncouples ligand-mediated receptor activa-tion from down-regulation 显示文摘	Monsonego-Oman E Adar R Feferman T	2000	Mol Cell Biol2000，20，：	1
15	Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling betweenIFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3 显示文摘	Feferman T Aricha R Mizrachi K	2009	J Neuroimmunol2009，209，：	1
16	Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors显示文摘	Souroujon MC Maiti PK Feferman T	2003	Ann N Y Acad Sci2003，998，：	1
17	Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment显示文摘	Maiti P K Feferman T Im S H	2004	Neuroimmunol2004，152，12：	1
18	Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors显示文摘	Souroujon M C Maiti P K Feferman T	2003	Ann N Y Acad Sci2003，998，：	1
19	Exvivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis显示文摘	Aricha R Feferman T Fuchs S	2008	Immunology2008，180，4：	1
20	Towards useful type-free theories 显示文摘	FEFERMAN S	1984	Journal of symbolic logic1984，，49：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示